Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer RiskYaohua Yang, Douglas A. Levine, Alicia Beeghly‐Fadiel et al.|Cancer Research|2018Cited by 62
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analysesEun Young Kang, P. Mackenzie, Dane Cheasley et al.|Modern Pathology|2020Cited by 43
Profiling the immune landscape in mucinous ovarian carcinomaNicola S. Meagher, Susan J. Ramus, Phineas T. Hamilton et al.|Gynecologic Oncology|2022Cited by 26